Clinical trial
Expanded Access Program for Maraviroc At Multiple Centers
NCT00426660 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00426660 |
|---|---|
| Title | Expanded Access Program for Maraviroc At Multiple Centers |
| Official title | A Multicenter, Open Label, Expanded Access Trial Of Maraviroc |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | maraviroc |
| Enrollment | 1,047 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jan 25, 2007 |
| Last update posted | Jun 29, 2016 |
| Countries | Argentina, Australia, Austria, Belgium, Canada, Chile, Costa Rica, Dominican Republic, France, Germany, Greece, Hong Kong and 14 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: